Therefore, our research group intends to apply PSMA- PET to elderly patients with PIRADS 5 lesions, to explore whether patients with PSMA- PET showing the possibility of prostate cancer can be directly treated with antitumor therapy without experiencing the pain and risk of operation. This evidence concerns the gene FOLH1 and Familial prostate cancer.